C WorldWide Group Holding A S Buys New Stake in Chemed Corporation $CHE

C WorldWide Group Holding A S bought a new stake in Chemed Corporation (NYSE:CHE) in the 4th quarter, HoldingsChannel.com reports. The firm bought 5,117 shares of the company’s stock, valued at approximately $2,189,000.

Other large investors have also recently made changes to their positions in the company. Smartleaf Asset Management LLC lifted its stake in shares of Chemed by 71.4% in the 3rd quarter. Smartleaf Asset Management LLC now owns 60 shares of the company’s stock valued at $27,000 after purchasing an additional 25 shares during the period. First Horizon Corp acquired a new position in shares of Chemed in the 3rd quarter valued at $31,000. Pilgrim Partners Asia Pte Ltd acquired a new position in shares of Chemed in the 3rd quarter valued at $45,000. Danske Bank A S lifted its stake in shares of Chemed by 250.0% in the 4th quarter. Danske Bank A S now owns 140 shares of the company’s stock valued at $60,000 after purchasing an additional 100 shares during the period. Finally, Geneos Wealth Management Inc. increased its holdings in Chemed by 330.4% in the 1st quarter. Geneos Wealth Management Inc. now owns 99 shares of the company’s stock worth $61,000 after acquiring an additional 76 shares in the last quarter. 95.85% of the stock is currently owned by institutional investors and hedge funds.

Chemed Price Performance

Chemed stock opened at $424.48 on Monday. Chemed Corporation has a 52-week low of $365.20 and a 52-week high of $583.96. The firm has a market capitalization of $5.63 billion, a price-to-earnings ratio of 23.13, a PEG ratio of 1.59 and a beta of 0.54. The company has a fifty day simple moving average of $396.39 and a 200-day simple moving average of $425.74. The company has a quick ratio of 0.83, a current ratio of 0.85 and a debt-to-equity ratio of 0.11.

Chemed (NYSE:CHE) last released its earnings results on Thursday, April 23rd. The company reported $5.65 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $5.30 by $0.35. Chemed had a net margin of 10.23% and a return on equity of 27.18%. The business had revenue of $657.51 million during the quarter, compared to analyst estimates of $659.22 million. During the same quarter in the prior year, the firm earned $5.63 earnings per share. The company’s revenue for the quarter was up 1.6% compared to the same quarter last year. Chemed has set its FY 2026 guidance at 24.000-24.75 EPS. On average, equities analysts anticipate that Chemed Corporation will post 22.3 EPS for the current fiscal year.

Chemed Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, March 13th. Stockholders of record on Monday, February 23rd were issued a dividend of $0.60 per share. The ex-dividend date of this dividend was Monday, February 23rd. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.6%. Chemed’s dividend payout ratio is presently 13.08%.

Insider Activity

In other news, CEO Kevin J. Mcnamara sold 2,000 shares of the company’s stock in a transaction on Friday, May 1st. The shares were sold at an average price of $421.13, for a total transaction of $842,260.00. Following the completion of the sale, the chief executive officer owned 90,219 shares of the company’s stock, valued at $37,993,927.47. This represents a 2.17% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 3.33% of the stock is owned by insiders.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on the stock. Royal Bank Of Canada boosted their price target on shares of Chemed from $422.00 to $436.00 and gave the stock a “sector perform” rating in a report on Monday, April 27th. Wall Street Zen raised shares of Chemed from a “hold” rating to a “buy” rating in a report on Saturday, May 2nd. Weiss Ratings raised shares of Chemed from a “sell (d+)” rating to a “hold (c-)” rating in a report on Wednesday, April 29th. Zacks Research raised shares of Chemed from a “strong sell” rating to a “hold” rating in a report on Monday, April 27th. Finally, Oppenheimer cut their price target on shares of Chemed from $580.00 to $500.00 and set an “outperform” rating for the company in a report on Friday, February 27th. Two analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. According to MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $501.50.

Chemed Company Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.